What is Zyris?
Zyris specializes in developing and providing advanced dental isolation technology, most notably the Zyris Isolite System. This system is engineered to facilitate hands-free operation for dental professionals, thereby boosting clinical efficiency and improving the overall patient experience. The product portfolio includes a range of mouthpieces and the innovative HOOPLA retractor, all designed to optimize patient comfort and clinical workflow. Zyris caters to a broad spectrum of clients, encompassing government agencies, educational institutions like dental schools, and specialized pediatric dentistry practices. With over two decades of industry experience, Zyris has played a crucial role in patient safety, having protected an estimated 80 million patients through its superior isolation, retraction, and illumination solutions.
How much funding has Zyris raised?
Zyris has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Zyris
PPP
Public-Private Partnership
What's next for Zyris?
The recent major strategic investment in Zyris signals a pivotal moment for the company, likely enabling accelerated product development, market penetration, and potentially the exploration of new technological frontiers in dental care. This capital injection is expected to fuel further innovation in their isolation and retraction solutions, reinforcing their competitive edge. The company's focus on enhancing efficiency and patient comfort positions it for continued success in both established and emerging markets. Future endeavors may include expanding their service offerings, forging new strategic partnerships, and further solidifying their reputation as a key provider of essential dental technology.
See full Zyris company page
